# Glofitamab in Real Life

> **NCT06994169** · — · RECRUITING · sponsor: **The Lymphoma Academic Research Organisation** · enrollment: 250 (estimated)

## Conditions studied

- Large B-cell Lymphoma

## Interventions

- **DRUG:** Glofitamab

## Key facts

- **NCT ID:** NCT06994169
- **Lead sponsor:** The Lymphoma Academic Research Organisation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2026-03-30
- **Final completion:** 2026-07-30
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06994169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06994169, "Glofitamab in Real Life". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06994169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*